sixth annual symposiumpersonalized interdisciplinary cancer treatment: the importance of timing
DESCRIPTION
This symposium will consist of four days dedicated to providing an update on personalized medicine and interdisciplinary cancer therapy approaches being developed and currently utilized to improve patient outcomes.TRANSCRIPT
The University of Texas M. D. Anderson Cancer Centerand M. D. Anderson Physicians Network
Sixth Annual SymposiumPersonalized Interdisciplinary Cancer Treatment:
The Importance of Timing
August 14–17, 2010
Oncology Nursing 2010: Empowered for ExcellenceAugust 14–15
New York Marriott Marquis1535 Broadway, New York, New York
GoalThis symposium will consist of four days dedicated to providing an update on personalized medicine and interdisciplinary cancer therapy approaches being developed and currently utilized to improve patient outcomes. Disease-site focused didactic and case presentations will focus on breast, esophageal, gastrointestinal (colon, gastric, liver, pancreas and rectal), head and neck, lung, melanoma, and sarcoma cancers.
CONTINUING MEDICAL EDUCATION
August 14-17, 2010 Sixth Annual SymposiumPersonalized Interdisciplinary Cancer Treatment: The Importance of Timing
CONTINUING NURSING EDUCATION
August 14-15, 2010Oncology Nursing 2010: Empowered for Excellence
The University of Texas M. D. Anderson Cancer Center and M. D. Anderson Physicians Network
New York Marriott Marquis1535 Broadway, New York, New York
Raphael E. Pollock, MD, PhD, Chair
George J. Chang, MDGary L. Clayman, MD, DMD, DDSJason B. Fleming, MDJeffrey E. Gershenwald, MDWayne L. Hofstetter, MDKelly K. Hunt, MD
Organizing Committee
Paul F. Mansfield, MDJean-Nicolas Vauthey, MDWilliam J. Simeone, Jr., MHACamerone A. Spoons, MBAConstance C. Tierney, CMP
Educational ObjectivesAfter attending the symposium, participants should be able to• Recognize the emergence and importance of targeted (disease-site specific)
personalized interdisciplinary approaches;• Identify the role, importance and timing of each discipline (medical, radiation
and surgery) for each cancer in an interdisciplinary manner;• Describe novel diagnostic and treatment approaches being developed and
implemented to optimize patient treatment outcomes.
Target AudienceThis symposium will be beneficial to medical oncologists, radiation oncologists, surgical oncologists, general surgeons, internists, physician assistants, oncology nurses, and advanced practice nurses involved in the care of patients with breast, esophageal, gastrointestinal, head and neck, melanoma, sarcoma and thoracic cancers.
Educational MethodLectures • Case Presentations Including Interactive Audience Participation Questions and Answers
EvaluationA course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.
Accreditation/Credit DesignationThe University of Texas M. D. Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas M. D. Anderson Cancer Center designates this educational activity for a maximum of 26.75 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CME Certificates and Attendance Verification CertificatesCertificates awarding AMA PRA Category 1 CreditTM or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form.
Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.
Saturday, August 14, 20106:30 a.m. Continental Breakfast/Registration
7:00 Introduction and Welcome William J. Simeone, Jr., MHA
7:10 Keynote Lecture: Contemporary Multimodality Approaches to Localized Malignancy: A Surgical Oncologist’s Perspective
Raphael E. Pollock, MD, PhD
7:45 Thoracic/Esophagus: Introduction: Wayne L. Hofstetter, MD
7:50 Current Approach to Dysplastic Barrett’s Esophagus Wayne L. Hofstetter, MD
8:15 Multidisciplinary Approach to Early Stage Esophageal Malignancy Ritsuko Komaki, MD
8:40 Surgical and Endoscopic Approaches to Early Stage Esophageal Cancer Thomas J. Watson, MD
9:05 Break
9:15 Metastatic Tumors to the Lung: Who is a Candidate for Resection? Ara A. Vaporciyan, MD
9:40 Advances in Targeted Therapy for Lung Cancer Edward S. Kim, MD
10:05 Stereotactic and Proton Radiation for NSCLC James D. Cox, MD
10:30 Break
10:40 Challenging Esophagus and Thoracic Cases Presentation with Interactive Audience Participation
Moderator: Wayne L. Hofstetter, MD and Esophagus and Thoracic Faculty Speakers
11:15 Break
11:25 Gastric: Introduction: Paul F. Mansfield, MD
11:30 Screening and Hereditary Gastric Cancer Robert S. Bresalier, MD
11:55 Contemporary Neoadjuvant Therapy for Gastric Cancer Paul F. Mansfield, MD
August 14-17, 2010 Personalized Interdisciplinary Cancer Treatment: The Importance of Timing
Program12:20 p.m. Combined Modality Therapy for Gastric Cancer Christopher Crane, MD
12:45 Laparoscopy and Curative Resection Options Vivian E. Strong, MD
1:05 Interdisciplinary Approaches When Cure is Not Possible Robert S. Bresalier, MD
1:30 Challenging Gastric Cases Presentation with Interactive Audience Participation
Moderator: Paul F. Mansfield, MD and Gastric Faculty Speakers
2:00 Adjourn
6:30 Welcome Reception
Sunday, August 15, 20106:45 a.m. Continental Breakfast/Registration
7:00 Liver: Introduction: Jean-Nicolas Vauthey, MD
7:05 Imaging Evaluation of Colorectal Liver Metastases Before and After Systemic Therapy
Evelyne M. Loyer, MD
7:25 Pre-operative Vascular Redistribution to Enhance Hepatic Resectability Jean-Nicolas Vauthey, MD
7:50 Regional Therapies for Colorectal Liver Metastases Mark S. Roh, MD
8:15 Break
8:25 Radiofrequency Ablation of Unresectable Liver Lesions Steven A. Curley, MD
8:50 Teaming With Medical Oncology: Systemic Therapy in the Multidisciplinary Approach to Metastatic Colorectal Cancer
Cathy Eng, MD
9:20 Biliary Tumors Involving the Liver Steven A. Curley, MD
9:45 Challenging Liver Cases Presentation and Interactive Audience Participation
Moderator: Jean-Nicolas Vauthey, MD and Liver Faculty Speakers
10:15 Break
10:25 Pancreas: Introduction: Jason B. Fleming, MD
10:30 Imaging the Pancreatic Mass When Malignancy Is Suspected Chusilp Charnsangavej, MD
10:50 Contemporary Biopsy and Tissue Diagnostic Approaches Jeffrey H. Lee, MD
11:10 The Use of Neoadjuvant Therapy in the Management of Borderline Resectable Tumors
Gauri R. Varadhachary, MD
11:40 Break
11:50 Combined Modality Therapy for Locally Advanced, Unresectable Pancreatic Cancer
Christopher Crane, MD12:20 p.m. New Options in Surgical Resection Jason B. Fleming, MD12:40 Novel Targets and Treatment of Pancreatic Cancer Gauri R. Varadhachary, MD1:10 Endoscopic and Surgical Palliative Approaches Jeffrey H. Lee, MD and Jason B. Fleming, MD1:30 Challenging Pancreatic Cases Presentation
with Interactive Audience Participation Moderator: Jason B. Fleming, MD and Pancreatic Cancer Faculty Speakers2:00 Adjourn
Monday, August 16, 2010 6:45 a.m. Continental Breakfast/Registration
7:00 Colorectal: Introduction: George J. Chang, MD
7:05 Update on Hereditary Colorectal Cancer: What Every Clinician Should Know Patrick M. Lynch, MD, JD7:25 Advances in Chemotherapy for Localized Colorectal Cancer Cathy Eng, MD7:50 Progress in Radiotherapy for Rectal Cancer: Treatment Frontiers Christopher Crane, MD8:10 Pathology Update: New Staging and Reporting Guidelines for Colorectal Cancer Stanley R. Hamilton, MD8:30 Break8:40 New Developments in Minimally Invasive Surgical Approaches
and Organ Preservation for Colorectal Cancer Y. Nancy You, MD9:00 Curative Multivisceral Resections for Locally Advanced
and Recurrent Colorectal Cancer George J. Chang, MD9:20 Quality of Life and Bowel Function after Multidisciplinary
Treatment of Rectal Cancer Larissa K. F. Temple, MD9:40 Novel Approaches in Multidisciplinary Treatment Development
for Localized Colon Cancer George J. Chang, MD10:00 Challenging Colorectal Cases Presentation with
Interactive Audience Participation Moderator: George J. Chang, MD and Colorectal Faculty Speakers 10:30 Break
10:40 Melanoma/Sarcoma: Introduction: Jeffrey E. Gershenwald, MD
10:45 The New AJCC Staging System and Beyond Jeffrey E. Gershenwald, MD
11:05 Management of Early Stage Melanoma–Does One Size Fit All? Merrick I. Ross, MD
11:25 Therapeutic Options in Recurrent Loco-Regional Melanoma Russell S. Berman, MD
11:45 Break
11:55 Targeted Therapy in Melanoma–Lessons Learned and Future Directions Michael Davies, MD, PhD
12:15 p.m. New Advances in Targeted Therapy for Gastrointestinal Stromal Tumors and Soft Tissue Sarcomas
Shreyaskumar Patel, MD
12:35 Gastrointestinal Stromal Tumors–A Model of Personalized Therapy Barry W. Feig, MD
12:55 Contemporary Approaches to Sarcoma of the Retroperitoneum and Abdomen
Raphael E. Pollock, MD, PhD
1:15 Challenging Melanoma and Sarcoma Cases Presentation with Interactive Audience Participation Moderator: Jeffrey E. Gershenwald, MD and
Melanoma and Sarcoma Faculty Speakers
2:00 Meet the Professor Session
3:30 Adjourn
Tuesday, August 17, 20106:45 a.m. Continental Breakfast/Registration
7:00 Head and Neck: Introduction: Gary L. Clayman, MD, DMD, DDS
7:05 The Emerging Importance of HPV Merrill S. Kies, MD
7:25 The Delivery of Personalized Radiation Therapy Based Upon Molecular, Pathologic and Disease-Patient Factors
Steven J. Frank, MD
7:50 The Value of Multidisciplinary Head and Neck Cancer Care Randal S. Weber, MD
8:10 Neoadjuvant Strategies and Evolution of Molecular Targeted Therapy Merrill S. Kies, MD
8:35 Break
Elizabeth S. Bloom, MDAssociate ProfessorRadiation Oncology Robert S. Bresalier, MDProfessor, Gastroenterology, Hepatology and Nutrition George J. Chang, MDAssistant ProfessorSurgical Oncology Chusilp Charnsangavej, MDProfessorDiagnostic RadiologyGary L. Clayman, MD, DMD, DDSProfessor Head and Neck SurgeryJames D. Cox, MDProfessor and Division HeadRadiation Oncology Christopher Crane, MDProfessor and ChiefGastrointestinal SectionRadiation Oncology Steven A. Curley, MDProfessorSurgical Oncology Michael Davies, MD, PhDAssistant ProfessorMelanoma Medical Oncology Cathy Eng, MDAssociate Professor Gastrointestinal Medical Oncology Barry W. Feig, MDProfessorSurgical OncologyJason B. Fleming, MDAssociate Professor Surgical Oncology Steven J. Frank, MDAssistant ProfessorRadiation Oncology
M. D. Anderson Symposium Faculty
Guest Faculty
Jeffrey E. Gershenwald, MDProfessor Surgical Oncology Stanley R. Hamilton, MDProfessor and Division HeadLaboratory Medicine and Pathology Wayne L. Hofstetter, MDAssociate ProfessorThoracic & Cardiovascular SurgeryChristopher Holsinger, MDAssociate ProfessorHead & Neck SurgeryKelly K. Hunt, MDProfessor and ChiefSurgical Breast SectionSurgical OncologyMerrill S. Kies, MDProfessor, Thoracic/Head & Neck Medical OncologyEdward S. Kim, MDAssociate Professor Thoracic/Head & Neck Medical OncologyRitsuko Komaki, MDProfessor and ChiefThoracic SectionRadiation OncologyHenry M. Kuerer, MD, PHDProfessor, Surgical OncologyDirector, Breast Surgical Oncology Training ProgramJeffrey H. Lee, MDProfessor, Gastroenterology, Hepatology and NutritionEvelyne M. Loyer, MDProfessorDiagnostic RadiologyAnthony Lucci, MDAssociate ProfessorSurgical Oncology
Patrick M. Lynch, MD, JDProfessor, Gastroenterology, Hepatology and Nutrition Paul F. Mansfield, MDProfessor Surgical Oncology Shreyaskumar Patel, MD, MSProfessor Sarcoma Medical Oncology Raphael E. Pollock, MD, PHDProfessor and Division HeadSurgical OncologyGeoffrey L. Robb, MDProfessor and ChairPlastic Surgery Merrick I. Ross, MDProfessorSurgical OncologyRoman Skoracki, MDAssociate Professor Plastic SurgeryVicente Valero, MDProfessorBreast Medical Oncology Ara A. Vaporciyan, MDAssociate Professor Thoracic & Cardiovascular Surgery Gauri R. Varadhachary, MDAssociate ProfessorGastrointestinal Medical OncologyJean-Nicolas Vauthey, MDProfessor and Chief Liver ServiceSurgical OncologyRandal S. Weber, MDProfessor and ChairHead & Neck SurgeryY. Nancy You, MDAssistant Professor Surgical Oncology
Russell S. Berman, MDAssistant Professor of SurgeryDirector, Surgical Residency Training Program NYU Langone Medical Center New York, New York
Mark S. Roh, MDChief, Surgical OncologyM. D. Anderson Cancer Center-Orlando Orlando, Florida
Thomas D. Shellenberger, MDHead and Neck SurgeryM. D. Anderson Cancer Center-Orlando Orlando, Florida
Vivian E. Strong, MDAssistant Attending of SurgeryMemorial Sloan-Kettering Cancer Center New York, New York
Larissa K. F. Temple, MDAssociate Attending of SurgeryMemorial Sloan-Kettering Cancer CenterAssociate ProfessorWeill Medical College of CornellNew York, New York
Thomas J. Watson, MDAssociate Professor of SurgeryThoracic and Foregut SurgeryUniversity of Rochester Medical CenterRochester, New York
The University of Texas M. D. Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. M. D. Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.
Agendas are subject to change because we are always striving to improve the quality of your educational experience. M. D. Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts, and so forth.
Photographing, audio taping and videotaping are prohibited.
8:45 Trans-Oral and Robotic Approaches in Head and Neck Cancer Christopher Holsinger, MD
9:05 Advances in Maxillary and Mandibular Reconstruction Techniques
Roman Skoracki, MD
9:25 Contemporary Approaches in the Management of Differentiated Thyroid Cancer Thomas D. Shellenberger, MD
9:45 Challenging Head and Neck Cases Presentation with Interactive Audience Participation Moderator: Gary L. Clayman, MD and Head and Neck Faculty Speakers
10:15 Break
10:25 Breast: Introduction: Kelly K. Hunt, MD10:30 Ductal Carcinoma In Situ: Updates on Biology and Treatment Henry M. Kuerer, MD, PhD
10:50 Nipple Sparing Mastectomy–When Less is More Anthony Lucci, MD
11:10 Sentinel Node Surgery Before or After Chemotherapy? Kelly K. Hunt, MD
11:30 Break
11:40 Partial Breast Irradiation: Patient Selection and Newer Techniques Elizabeth S. Bloom, MD
12:05 p.m. Improving Local Therapy Options in Locally Advanced Breast Cancer Henry M. Kuerer, MD, PhD
12:25 Novel Treatment Strategies for Inflammatory Breast Cancer Anthony Lucci, MD
12:45 State-of-the-Art in Breast Reconstruction Geoffrey L. Robb, MD
1:05 Personalizing Adjuvant Therapy in Breast Cancer Treatment Vicente Valero, MD
1:30 Challenging Breast Cancer Cases Presentation with Interactive Audience Participation
Moderator: Kelly K. Hunt, MD and Breast Cancer Faculty Speakers
2:00 Adjourn
Saturday, August 14, 20106:15 a.m. Registration/Continental Breakfast
6:45 Introduction and Welcome Laurie Sturdevant, BA, RN, OCN
7:00 Chemotherapy Safety Standards: Their Time Has Come Marty Polovich, MN, RN, AOCN
8:00 Chemotherapy Standards: Effects on Nursing Practice: Group Discussions and Q&A Marty Polovich, MN, RN, AOCN & Committee Leaders
8:30 Proton Therapy Haihong Cai, MS, RN, ANP
9:45 Break
10:00 Proton Therapy Group Discussions-Care of the Patients Post Treatment and Q&A Haihong Cai, MS, RN, ANP & Committee Leaders
10:30 Improving Shared Decision-Making: Building Intraprofessional Partnerships through PACTs (Professional Action Coordinating Teams) Patty Johnston, OCN, RN, MS, BSN
11:30 Break
Noon Emerging Trends in Acute LeukemiaKathy Mishaw, MSN, RN, AOCN
1:15 p.m. Distress in the Cancer Patient Mary K. Hughes, RN, BS, MS, CNS
2:15 Evaluations
2:45 Adjourn
Oncology Nursing 2010: Empowered for Excellence(See registration form for separate registration and fee. For those wishing to attend the Monday and Tuesday of the Symposium, the cost will be $75 additional.)
Goal: A two-day program designed to introduce nurses to recent developments in chemotherapy administration standards, and improvements in safety methodologies for hazardous drug handling. We will explore a modern systematic approach to quality decision making, first and second line therapies for the treatment of acute leukemias, and the fundamentals of proton therapy. We will also convey the principles for recognizing stress and addressing sexuality in the cancer patient.
Educational Objectives: After attending the conference, participants should be able to
• Discuss updates for nurses involved in the administration of chemotherapy relative to the associated safety issues affecting patients and personnel and allow for discussion of potential practice changes.
• Explore proton therapy as a treatment modality including patient selection and allow for a dialogue to assist nurses in identifying practice issues.
• Determine the applicability of the M. D. Anderson Cancer Center Professional Action Coordinating Teams (PACTS) approach to developing quality nursing practice processes.
• Explain options for first and second line treatment modalities for patients diagnosed with Acute Myologenous Leukemia and Acute Lymphocytic Leukemia.
• Review nursing tools that will assist nurses to identify distress in the oncology patient and formulate appropriate interventions.
• Identify updates relevant to the handling of hazardous drugs and allow for discussions about potential changes in nursing practice.
• Discuss the application of genetics in the planning of care for oncology patients.
• Distinguish tools that will assist nurses in recognizing actual/potential sexual dysfunction among oncology patients.
Nursing Credits: Nursing Continuing Education Contact Hours will be awarded.
Shannon Crews, RN, OCNClinical Leader, Cancer Care CenterSoutheast Georgia Health SystemBrunswick, Georgia
Lisa G. Green, MSN, RN, AOCNProgram Manager, NPDEM. D. Anderson Cancer CenterHouston, Texas
Janice L. Kitchens, BSN, RN, OCNManager, Healthcare ServicesM. D. Anderson Physicians NetworkHouston, Texas
Connie Popper, RN, MSNClinical Practice Improvement ConsultantM. D. Anderson Cancer Center-OrlandoOrlando, Florida
AUGUST 14-15, 2010 ONCOLOGY NURSINGPROGRAM
Organizing Committee
Charlotte Pyle, RN, OCNAssistant ManagerOutpatient Care CenterCancer InstituteSaint Francis Medical CenterCape Girardeau, Missouri
Laurie Sturdevant, BA, RN, OCNManager, Quality Improvement ProgramsM. D. Anderson Physicians NetworkHouston, Texas
REGISTRATION INFORMATION• On-site registration for The University of Texas M. D. Anderson Cancer Center and
M. D. Anderson Physicians Network Sixth Annual Symposium opens at 6:30 a.m. on Saturday, August 14, 2010. The opening session of the symposium will begin at 7:00 a.m. on Saturday, August 14, and the symposium will adjourn on Tuesday, August 17.
• On-site registration for Oncology Nursing 2010: Empowered for Excellence opens at 6:15 a.m. on Saturday, August 14, 2010. The opening session of the conference will begin at 6:45 a.m., and the conference will adjourn on Sunday, August 15, 2010.
• Advance registration is encouraged as space and materials are limited. Please see registration form for applicable fees.
The deadline for advance registration is July 23, 2010.
There are three ways to register:• Mail to: CME/Conference Management – Unit 1381, The University of Texas M. D. Anderson
Cancer Center, P.O. Box 301439, Houston, TX 77230-1439• Fax to: 713-794-1724• On-line at www.mdanderson.org/conferences
We accept the following forms of payment:• Check (payable through U.S. banks only)• Money Order• Credit Cards (MasterCard, VISA, and American Express)• Cash (on-site registration only)
A receipt and confirmation letter will be sent to you within ten working days of receipt of your fee.
The full conference registration fee includes the tuition, abstract book, continental breakfasts, breaks, and welcome reception.
REFUND/CANCELLATION POLICY The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before July 23, 2010. No refunds will be granted after that date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. Although no refunds will be granted after July 23, 2010, you may transfer your registration to a colleague.
The Department of CME/Conference Management reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.
In case of activity cancellation, liability of the Department of CME/Conference Management is limited to the registration fee. CME/Conference Management will refund the full registration fee. The Department of CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.
For additional information, contact CME/Conference Management at 713-792-2223 or toll free at 866-849-5866.
Sunday, August 15, 20106:15 a.m. Registration/Continental Breakfast
6:45 Introduction and Welcome Janice L. Kitchens, BSN, RN, OCN
7:00 Reducing Exposure to Hazardous Drugs: What Oncology Nurses Need to Know
Seth Eisenberg, RN, OCN
8:15 Hazardous Drugs: Group Discussions and Q&A Seth Eisenberg, RN, OCN & Committee Leaders
8:45 Genetics: A Primer for the Nurse Kathy Mishaw, MSN, RN, AOCN
10:00 Break
10:15 New Era of Genetic Based Strategies for Cancer Treatment: Predictive, Personalized, Preventive
Kathy Mishaw, MSN, RN, AOCN
11:30 Break
Noon Genetics: Discussion and Q&A Kathy Mishaw, MSN, RN, AOCN & Committee Leaders
1:00 p.m. Sexuality and the Cancer PatientMary K. Hughes, RN, BS, MS, CNS
2:00 Sexuality and the Cancer Patient Q&A
2:15 Evaluations
2:45 Adjourn
Kathy Mishaw, MSN, RN, AOCN Advanced Practice NurseNursing Education SpecialistNursing Extramural Programs Mary K. Hughes, RN, BS, MS, CNS Advanced Practice Nurse Department of Psychiatry Haihong Cai, MS, RN, ANPAdvanced Practice Nurse Proton Therapy Center Patty Johnston, OCN, RN, MS, BSN Associate Director, Clinical Nursing Department of Stem Cell Transplantation and Cellular Therapy
Seth Eisenberg, RN, OCN Seattle Cancer Care Alliance Professional Practice Coordinator, Infusion Services, Seattle, Washington
Marty Polovich, MN, RN, AOCNDuke Oncology Network Associate Director, Clinical OperationsDurham, North Carolina Project Co-chairComprehensive Safety Standards for Chemotherapy Administration To Ensure Quality Care For Cancer PatientsAmerican Society of Clinical Oncology/ Oncology Nursing Society (ASCO/ONS)
M. D. Anderson Faculty Guest Faculty
Last
Nam
e
F
irst
M
I
H
ighe
st D
egre
e
Depa
rtm
ent (
inclu
de b
ox n
o.)
Spe
cialty
Inst
itutio
n
Stre
et
C
ity
Stat
e/Fo
reign
Cou
ntry
/Zip
or M
ail C
ode
Dayt
ime
Phon
e (w
ith a
rea
code
)
Ce
ll Pho
ne (w
ith a
rea
code
)
Fax (
with
are
a co
de)
E-m
ail A
ddre
ss
Emer
genc
y Co
ntac
t
P
hone
(with
are
a co
de)
Char
ge th
e fo
llowi
ng:
oVI
SA
o
Mas
terC
ard
oAm
erica
n Ex
pres
s
Card
Num
ber o
r M. D
. And
erso
n In
terd
epar
tmen
tal T
rans
fer (
IDT)
No.
Exp
iratio
n Da
te
Auth
orize
d Si
gnat
ure
REQU
IRED
for c
redi
t car
d or
IDT
M. D
. And
erso
n Em
ploy
ee ID
No.
(REQ
UIRE
D)
CONF
EREN
CE R
EGIS
TRAT
ION-
0496
PHYS
ICIA
NS A
ND N
URSE
S: T
he U
nive
rsity
of T
exas
M. D
. And
erso
n Ca
ncer
Cen
ter
and
M. D
. And
erso
n Ph
ysic
ians
Net
wor
k Si
xth
Annu
al S
ympo
sium
: Per
sona
lized
In
terd
isci
plin
ary
Canc
er T
reat
men
t: Th
e Im
port
ance
of T
imin
g - A
ugus
t 14–
17, 2
010
NURS
ES: O
ncol
ogy
Nurs
ing
2010
: Em
pow
ered
for E
xcel
lenc
e - A
ugus
t 14–
15, 2
010
THIS
IS N
OT A
SEL
F-M
AILE
R-Ad
dres
s to
: Th
e Un
ivers
ity o
f Tex
as M
. D. A
nder
son
Canc
er C
ente
r and
M
. D. A
nder
son
Phys
icia
ns N
etw
ork
Sixt
h An
nual
Sym
posiu
mDe
partm
ent o
f CM
E/Co
nfer
ence
Man
agem
ent –
Uni
t 138
1Th
e Un
iver
sity
of T
exas
M. D
. And
erso
n Ca
ncer
Cen
ter
PO B
ox 3
0143
9, H
oust
on, T
X 77
230-
1439
or fa
x to
713
-794
-172
4 M
ake
chec
k or
mon
ey o
rder
pay
able
to:
The
Univ
ersi
ty o
f Tex
as M
. D. A
nder
son
Canc
er C
ente
r
REGI
STRA
TION
FEE
SSi
xth
Annu
al S
ympo
sium
, Aug
ust 1
4–17
, 201
0Ph
ysic
ians
(MDs
, PhD
s, DO
s) 1
Pos
tmar
ked
befo
re 7
/23/
10 ...
......
......
......
$550
.00
1 P
ostm
arke
d af
ter 7
/23/
10 ...
......
......
......
...$6
00.0
0
M. D
. And
erso
n Al
umni
/Phy
sici
ans
Netw
ork
1 P
ostm
arke
d be
fore
7/2
3/10
......
......
......
...$4
50.0
0 1
Pos
tmar
ked
afte
r 7/2
3/10
......
......
......
......
$500
.00
Fello
ws,
Phys
icia
n As
sist
ants
, Nur
ses,
Resi
dent
s 1
Pos
tmar
ked
befo
re 7
/23/
10 ...
......
......
......
$350
.00
1 P
ostm
arke
d af
ter 7
/23/
10 ...
......
......
......
...$3
75.0
0
Onco
logy
Nur
sing
201
0:
Empo
wer
ed fo
r Exc
elle
nce
- Aug
ust 1
4–15
, 201
0 1
Pos
tmar
ked
befo
re 7
/23/
10 ...
......
......
......
$300
.00
1 P
ostm
arke
d af
ter 7
/23/
10 ...
......
......
......
...$3
25.0
0 1
$75
add
ition
al to
atte
nd S
ympo
sium
Aug
ust 1
6–17
SPECIAL ASSISTANCEContact the Department of CME/Conference Management at 713-792-2223 or toll free at 866-849-5866 if you have any special dietary or ADA accommodation needs.
ACCOMMODATIONS• A block of rooms has been reserved for symposium attendees at the New York
Marriott Marquis, 1535 Broadway, New York, New York.• Early hotel reservation is suggested. • The hotel phone number is 212-398-1900. • When you make reservations be sure to mention The University of Texas
M. D. Anderson and M. D. Anderson Physicians Network Sixth Annual Symposium to be assured of receiving the special meeting rate of $259.00 single or double occupancy. Please add 14.75% New York state and local taxes and $3.50 occupancy tax.
• Reservations and deposits received after June 25, 2010 will be confirmed if space is available and at current hotel published guest room rates.
AIR TRAVELM. D. Anderson has a program with Continental Airlines for discounted air travel. For discounts, call your travel professional or Continental’s MeetingWorks toll free at 800-468-7022. Outside of the United States, please call your local Continental Airlines Reservation Office. Mention Z Code: ZG6C and Agreement Code: DK9EJX.
GROUND TRANSPORTATIONThe hotel is approximately 10-15 miles from the three airports – La Guardia, JFK and Newark. Taxis are available at the approximate price of $60 one way. Super Shuttle is also available. Please call 800-258-3826 or book on line at www.supershuttle.com.
Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Fax or e-mail CME/Conference Management. All responses will be forwarded to the Program Chair for consideration.
Depa
rtm
ent o
f CM
E/Co
nfer
ence
Man
agem
ent-
Unit
1381
The
Univ
ersi
ty o
f Tex
as M
. D. A
nder
son
Canc
er C
ente
r#1
7670
0/30
0704
96PO
Box
301
439
Hous
ton,
TX
7723
0-14
39
Non
-Pro
fit O
rg.
U.S
. Pos
tage
P A
I D
Hou
ston
, TX
Perm
it N
o. 7
052